Medication for management of pregnancy-induced hypertension

Por um escritor misterioso
Last updated 19 setembro 2024
Medication for management of pregnancy-induced hypertension
Hypertension refers to increased arterial blood pressure and can be divided into two categories: primary and secondary. Primary hypertension caused by angiogenic degenerative changes is a degenerative disease. With liberalization of China’s reproduction policy and increases in maternal age, the prevalence of pregnancy-induced hypertension (PIH) in China has increased gradually. PIH is not a type of primary hypertension, but there are differences in the treatment of these two types of hypertension. Here, we review the choice and use of drugs for PIH management using drugs for the management of primary hypertension as a reference. First-line drugs such as labetalol, nifedipine, or methyldopa should be taken via the oral route if blood pressure is ≥ 150/90 mmHg. For chronic hypertension, other drugs should be added after the first drug at the highest concentration has been revealed to be ineffective. If the blood pressure of patients with acute hypertension is ≥ 160/110 mmHg, maternal stroke or eclampsia can result. If PIH patients are about to deliver, they can be given labetalol (i.v.), hydralazine (i.v.) or nifedipine (p.o.). Moreover, all anti-hypertensive treatments should be based on considerations of maternal and fetal safety.
Medication for management of pregnancy-induced hypertension
IJERPH, Free Full-Text
Medication for management of pregnancy-induced hypertension
MANAGEMENT OF PREGNANCY INDUCED HYPERTENSION
Medication for management of pregnancy-induced hypertension
Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy - Canadian Journal of Cardiology
Medication for management of pregnancy-induced hypertension
Nutrients, Free Full-Text
Medication for management of pregnancy-induced hypertension
PDF) Medication for management of pregnancy-induced hypertension
Medication for management of pregnancy-induced hypertension
Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy
Medication for management of pregnancy-induced hypertension
Drugs in Gestational Hypertension – The Early Career Voice
Medication for management of pregnancy-induced hypertension
Gestational hypertension
Medication for management of pregnancy-induced hypertension
Hypertension in pregnancy: Pathophysiology and treatment
Medication for management of pregnancy-induced hypertension
Hypertensive Disorders of Pregnancy, 2004-11-15
Medication for management of pregnancy-induced hypertension
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet
Medication for management of pregnancy-induced hypertension
Lesson: Review of Hypertension in Pregnancy for Pharmacists
Medication for management of pregnancy-induced hypertension
Cover Story Gestational Hypertension and Preeclampsia: Nontraditional Risk Factors For Cardiovascular Disease - American College of Cardiology

© 2014-2024 galemiami.com. All rights reserved.